Brochure
21 Jun 2021

Delpharm Overview

PDF 276 kB

Delpharm is a European leader in contract manufacturing and development of medicines for pharmaceutical laboratories. It owns 12 manufacturing plants (nine in France, two in Italy and one in Belgium) providing the majority of dosage forms available on the market: tablets, syrups, bottles, vials, etc. Delpharm generates €500m in turnover and is wholly-owned by its management. For more information, visit our website: http://www.delpharm.com/

Content provided by our supplier

DELPHARM

  • FR
  • 2021
    On CPHI since
  • 4
    Certificates
  • 1000 - 4999
    Employees
Company types
Contract Service

Other Content from DELPHARM ()